These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10473991)

  • 1. Evaluation of DNA ploidy combined with a cytometric proliferation index of imprints from core needle biopsies in prostate cancer.
    Ahlgren G; Falkmer U; Gadaleanu V; Abrahamsson PA
    Eur Urol; 1999 Oct; 36(4):314-9. PubMed ID: 10473991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation.
    Diaz JI; Mora LB; Austin PF; Muro-Cacho CA; Cantor AB; Nicosia SV; Pow-Sang JM
    Urology; 1999 May; 53(5):931-8. PubMed ID: 10223486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
    Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
    Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
    Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ
    J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.
    Stege R; Grande M; Carlström K; Tribukait B; Pousette A
    Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
    Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group.
    van den Ouden D; Tribukait B; Blom JH; Fossa SD; Kurth KH; ten Kate FJ; Heiden T; Wang N; Schroder FH
    J Urol; 1993 Aug; 150(2 Pt 1):400-6. PubMed ID: 8326563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?
    Brinker DA; Ross JS; Tran TA; Jones DM; Epstein JI
    J Urol; 1999 Dec; 162(6):2036-9. PubMed ID: 10569563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.
    Venkataraman G; Heinze G; Holmes EW; Ananthanarayanan V; Bostwick DG; Paner GP; Bradford-De La garza CM; Brown HG; Flanigan RC; Wojcik EM
    Prostate; 2007 Oct; 67(14):1524-36. PubMed ID: 17683063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
    Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
    Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
    Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
    Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA image cytometry of prostatic carcinoma: a comparison of needle core biopsy and subsequent prostatectomy specimens.
    Leung CS; Zbieranowski I; Demers J; Murray D
    Mod Pathol; 1994 Feb; 7(2):195-9. PubMed ID: 8008743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor heterogeneity of prostate carcinoma by flow- and image DNA cytometry and histopathological grading.
    Wang N; Wilkin C; Böcking A; Tribukait B
    Anal Cell Pathol; 2000; 20(1):49-62. PubMed ID: 11007438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA image cytometry on biopsies can help the detection of localized Gleason 3+3 prostate cancers.
    Lorenzato M; Rey D; Durlach A; Bouttens D; Birembaut P; Staerman F
    J Urol; 2004 Oct; 172(4 Pt 1):1311-3. PubMed ID: 15371830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry.
    So MJ; Cheville JC; Katzmann JA; Riehle DL; Lohse CM; Pankratz VS; Sebo TJ
    Mod Pathol; 2001 Sep; 14(9):906-12. PubMed ID: 11557788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.